Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma

NCT01448096 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Large B Cell Diffuse Lymphoma

Interventions

DRUG: Rituximab
PROCEDURE: Prophylactic intrathecal chemotherapy

Sponsor

Chonbuk National University Hospital

Collaborators

[object Object]